{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:36:20Z","timestamp":1697776580993},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":8569,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[1983,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A chemotherapy regimen consisting of hexamethylmelamine (H) 150 mg\/ m<jats:sup>2<\/jats:sup> orally days 1\u201314, cyclophosphamide (C) 500 mg\/m<jats:sup>2<\/jats:sup> IV day 1 of a 28\u2010day cycle with Adriamycin (A) 40 mg\/m<jats:sup>2<\/jats:sup> IV day 1 alternating with cisdiamminechloroplatinum (C\u2010P) 50 mg\/m<jats:sup>2<\/jats:sup> IV day 1 every other cycle was administered to 29 patients with advanced epithelial ovarian cancer. Toxicity to this regimen included alopecia, nausea, and vomiting in all patients. Mild paresthesias occurred in four patients. Hematologic toxicity required only minimal dose modification. There was no cardiac, renal, or auditory toxicity. The clinical response rate of 55% and median survival of 14 months compare favorably with that of other reported series. This chemotherapy regimen seems to be well tolerated without jeopardizing the patients' response.<\/jats:p>","DOI":"10.1002\/jso.2930220206","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T08:50:59Z","timestamp":1171961459000},"page":"87-91","source":"Crossref","is-referenced-by-count":3,"title":["Alternating multiagent chemotherapy for advanced ovarian cancer"],"prefix":"10.1002","volume":"22","author":[{"given":"Enrique","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil B.","family":"Rosenshein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Ettinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley E.","family":"Order","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"81","article-title":"Current status of therapeutic modalities for treatment of gynecologic malignancies with emphasis on chemotherapy","volume":"141","author":"Willson JKV","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_3_2","first-page":"241","article-title":"Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma vs. minimal residual disease","volume":"63","author":"Edmonson JH","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197201)29:1<1::AID-CNCR2820290102>3.0.CO;2-Y"},{"key":"e_1_2_1_5_2","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma: Symposium on ovarian cancer","volume":"42","author":"Griffiths CT","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(16)41440-4"},{"key":"e_1_2_1_7_2","first-page":"235","article-title":"Role of cytoreductive surgical treatment in the management of advanced ovarian cancer","volume":"63","author":"Griffiths CT","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1980.01380070051011"},{"key":"e_1_2_1_9_2","first-page":"325","article-title":"Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: A preliminary report of a Southwest Oncology Group Study","volume":"63","author":"Alberts DS","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1148\/93.3.659"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(79)90950-5"},{"key":"e_1_2_1_12_2","first-page":"609","article-title":"Single agent vs. combination chemotherapy in the treatment of ovarian cancer","volume":"49","author":"Barlow JJ","year":"1977","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_13_2","first-page":"311","article-title":"The CHAD and HAD regimens in advanced ovarian cancer: Combination chemotherapy including cyclophosphamide hexamethylmelamine, adriamycin and cis\u2010dichlorodiamineplatinum","volume":"63","author":"Vogl SE","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(80)90135-3"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800201)45:3<572::AID-CNCR2820450325>3.0.CO;2-3"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197812072992301"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810715)48:1 <590::AID-CNCR2820481324>3.0.CO;2-E"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-95-1-98"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.2930220206","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.2930220206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T22:29:24Z","timestamp":1697754564000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.2930220206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1983,2]]}},"alternative-id":["10.1002\/jso.2930220206"],"URL":"https:\/\/doi.org\/10.1002\/jso.2930220206","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,2]]}}}